Omeros Corporation
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$5.3M
Doctors Paid
4,299
Transactions
10,296
2021 Total
$1.6M
Payment Breakdown by Category
Research$2.8M (53.8%)
Consulting$1.4M (26.7%)
Food & Beverage$256,920 (4.9%)
Travel$105,922 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.8M | 249 | 53.8% |
| Consulting Fee | $1.4M | 455 | 26.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $357,914 | 141 | 6.8% |
| Food and Beverage | $256,920 | 8,990 | 4.9% |
| Honoraria | $238,732 | 81 | 4.5% |
| Travel and Lodging | $105,922 | 360 | 2.0% |
| Education | $66,607 | 19 | 1.3% |
| Grant | $3,000 | 1 | 0.1% |
Payments by Type
Research
$2.8M
240 transactions
General
$2.4M
10,047 transactions
Ownership
$0
9 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| OMS721-GNP-001 | $1.2M | 15 | 150 |
| An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients | $636,578 | 0 | 24 |
| OMS 721-TMA-001 | $295,119 | 0 | 10 |
| A Retrospective Study to Determine the Incidence of, Risk Factors for, and Outcomes of Patients with Transplant-Associated Thrombotic Microangiopathy (TA-TMA) After Allogeneic Hematopoietic Cell Transplantation | $268,900 | 0 | 11 |
| OMS302-ILR-007 | $101,490 | 0 | 21 |
| Pain Control and Reduction in Opioid Use | $50,000 | 0 | 2 |
| Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721 | $31,549 | 0 | 2 |
| OMS721-TMA-001 | $16,076 | 0 | 15 |
| OMS824-HTD-002 | $2,122 | 0 | 1 |
| OMS182399 | $700.00 | 1 | 2 |
Payments by Medical Specialty
Top Paid Doctors — Page 10
| Doctor | Specialty | Location | Total | 2019 |
|---|---|---|---|---|
| Dr. Nancy Coles, Md, MD | Ophthalmology | New York, NY | $246.02 | $0 |
| Baruch Gorman, M.d, M.D | Ophthalmology | Boynton Beach, FL | $246.02 | $0 |
| Charles Schaffer, M.d, M.D | Ophthalmology | Las Cruces, NM | $245.72 | $0 |
| Hannah Powers, Od, OD | Optometrist | Evansville, IN | $244.06 | $0 |
| Dr. Ranya Habash, M.d, M.D | Ophthalmology | Boca Raton, FL | $244.05 | $0 |
| John Flanagan, M D, M D | Ophthalmology | New York, NY | $243.80 | $0 |
| Jennifer Hartel, M.d, M.D | Cornea and External Diseases Specialist | Columbia, SC | $242.81 | $0 |
| Arati Pandya, Md, MD | Ophthalmology | Conyers, GA | $242.74 | $0 |
| Dr. Karl Stonecipher, Md, MD | Ophthalmology | Greensboro, NC | $239.84 | $0 |
| Kenneth Rosenthal, Md, MD | Ophthalmology | Great Neck, NY | $239.82 | $0 |
| Dr. Sara Stoneburner, M.d, M.D | Specialist | Greensboro, NC | $239.09 | $0 |
| Dr. Stephen Nagy, M.d, M.D | Ophthalmology | Winston-Salem, NC | $238.95 | $0 |
| Dr. Sudeep Das, M.d, M.D | Ophthalmology | Charleston, SC | $238.45 | $0 |
| John Aljian, Md, MD | Cornea and External Diseases Specialist | Hawthorne, NY | $237.17 | $0 |
| Douglas Grayson, M.d, M.D | Ophthalmology | Iselin, NJ | $237.17 | $0 |
| Dr. Sumayya Ahmad, M.d, M.D | Cornea and External Diseases Specialist | Long Island City, NY | $237.17 | $0 |
| Dr. Kira Manusis, M.d, M.D | Ophthalmology | Brooklyn, NY | $237.17 | $0 |
| M Wilson, Md, MD | Ophthalmology | Charleston, SC | $237.06 | $0 |
| Nunzio Sossi, M.d..phd, M.D..PHD | Ophthalmology | Jupiter, FL | $234.27 | $0 |
| Dr. Deval Joshi, M.d, M.D | Ophthalmology | Boynton Beach, FL | $234.27 | $0 |
| Philip Laird, Md, MD | Ophthalmology | Palm Beach Gardens, FL | $234.27 | $0 |
| Kevin Kelly, Md, MD | Ophthalmology | Wellington, FL | $234.27 | $0 |
| Joseph Nezgoda, M. D, M. D | Ophthalmology | West Palm Beach, FL | $234.26 | $0 |
| George Pronesti, M.d, M.D | Ophthalmology | King Of Prussia, PA | $233.94 | $0 |
| Dr. Quentin Allen, M.d, M.D | Ophthalmology | Stuart, FL | $231.11 | $0 |
Ad
Top Products
- Omidria $1.3M
- OMIDRIA $738,978
Associated Products (4)
- Omidria $1.6M
- OMIDRIA $896,672
- Narsoplimab $391,825
- narsoplimab $84,617
Payment Categories
- Food & Beverage $256,920
- Consulting $1.4M
- Travel & Lodging $105,922
- Research $2.8M
About Omeros Corporation
Omeros Corporation has made $5.3M in payments to 4,299 healthcare providers, recorded across 10,296 transactions in the CMS Open Payments database. In 2021, the company paid $1.6M. The top product by payment volume is Omidria ($1.3M).
Payments were distributed across 87 medical specialties. The top specialty by payment amount is Ophthalmology ($1.5M to 2,549 doctors).
Payment categories include: Food & Beverage ($256,920), Consulting ($1.4M), Research ($2.8M), Travel & Lodging ($105,922).
Omeros Corporation is associated with 4 products in the CMS Open Payments database, including Omidria, OMIDRIA, and Narsoplimab.